Artiva Biotherapeutics, Inc. (ARTV) vs Nautilus Biotechnology, Inc. (NAUT)
- Artiva Biotherapeutics, Inc. ARTV 5.85 −3.47%
- Nautilus Biotechnology, Inc. NAUT 2.06 −4.63%
Artiva Biotherapeutics, Inc. and Nautilus Biotechnology, Inc. are both Biotechnology companies. Artiva Biotherapeutics, Inc. and Nautilus Biotechnology, Inc. are of similar size ($296.3M and $274.9M). Across the 9 metrics below, Artiva Biotherapeutics, Inc. leads on 5 and Nautilus Biotechnology, Inc. on 4.
Valuation
Profitability
| Metric | ARTV | NAUT | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (36.58%) | (36.21%) | (56.36%) |
| Return on assets | (33.76%) | (30.00%) | (48.04%) |
| Return on invested capital | 0.00% | (83.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack